John Deluca, MD
Internal Medicine · North Palm Beach, FLNPI 1407050024
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $51,660 of the $68,681 with a category attached, or 75.2%. Biogen accounts for 99.7% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $32,363 and has fallen 99.8% since, to $55 in 2024. Among internal medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 56 payments — averaging $1226.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$68K
- Novartis$70
- Reddress USA, Inc.$42
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$40
- Novo Nordisk$19
- Takeda Pharmaceuticals U.S.A., Inc.$13
What the payments were for
- Consulting fees$51,66075%
- Speaking & faculty fees$5,7458%
- Travel & lodging$10,31415%
- Food & beverage$9621%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 50 | $68,498 |
| Novartis | 1 | $70 |
| Reddress USA, Inc. | 1 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $40 |
| Novo Nordisk | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
How this compares
$68,681 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OmnitropeSomatropin | 13 | $8,355 |
| Np ThyroidThyroid,pork | 18 | $1,540 |
| Liothyronine Sodium | 19 | $1,138 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $652 |
| Hydrocortisone | 14 | $648 |
| Testosterone Cypionate | 11 | $411 |
| Lisinopril | 14 | $345 |
| ProgesteroneProgesterone, Micronized | 11 | $259 |
| Hydroxychloroquine Sulfate | 13 | $215 |
| Anastrozole | 16 | $145 |
| Fluconazole | 16 | $140 |
| Azithromycin | 12 | $76 |
| Metformin Hcl | 22 | $73 |
| Amitriptyline Hcl | 13 | $34 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in North Palm Beach
- Haytham ElgammalMiami$2.2M
- Keith RubinFort Lauderdale$2M
- Michael SensionFort Lauderdale$1M
- Quang NguyenOcala$434K
- Luis Correa LunaSanford$412K
- Michael OleksykFort Myers$365K
- Andrew KuykendallTampa$322K
- Howard FederoffCoconut Grove$302K
- Bianka EperjesiovaGainesville$260K
- Julio ConradoFort Myers$247K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.